When My Frustrated Staff Said, “We Need Another Option,” I Found OSRX

Dr. Sydney L. Tyson founded Eye Associates & SurgiCenter of Vineland (N.J.) in 1999, a medical and surgical ophthalmology practice that has expanded to six offices serving southern New Jersey and greater Philadelphia, Pa.

My Patients Having Surgery Today Will Have a Quiet Post-op Period Because I Have a Trusted Partner, a Pharmacy I Know Well

Dr. Shachar Tauber, a practicing physician for more than 20 years is the Director of Ophthalmology Research, Cornea and Refractive Surgery at Mercy Clinic in Springfield, Mo., where he and fellow surgeons are the first to provide laser-assisted cataract surgery in Southwest Missouri.

Ocular Science Medical Advisory Board Expands to 30 Leaders in Ophthalmology and Optometry from Around the Country

Physicians William Trattler and Jennifer Loh join the biotech’s leadership team.

Ocular Science Appoints Kip Crecca to Its Board of Directors

Crecca, a long-time industry commercialization professional, to supply expertise on medical device sales, production, distribution and customer support.

Ocular Science Medical Advisory Board Expands to 28 Leaders in Ophthalmology and Optometry from Around the Country

Jacqueline Griffiths, MD, with nearly 30 years of experience, is joining a board that establishes strategies to focus on enhanced clinical solutions, products and patient outcomes for Ocular Science and affiliated PCAB-accredited 503A compounding pharmacy, OSRX.

‘Patients First’ Is My Mission, So OSRX Is My Compounding Pharmacy

My practice is founded on the belief that the company behind the product must deliver great customer service and every patient should have a personalized care plan for both their eye condition and eye surgery. We focus on getting to know our patients and connecting with them, not transactions or numbers. This “patients first” philosophy is what led us to enlist OSRX as our compounding pharmacy.

Minimizing Patient Eye Drop Confusions Was Job No. 1 for My New Ophthalmology Practice

After 10 years at an academic practice, Dr. Preeya K. Gupta opened her own ophthalmology practice in July. As the founder and managing director of Triangle Eye Consultants, Dr. Gupta and her team immediately began using compounded eye drops from OSRX.

Compounded Post-Op Drops Are A Game Changer

Dr. Luke Rebenitsch is an internationally acclaimed vision correction surgeon and the Chief Medical Director of ClearSight Center in Oklahoma City. He is a leading expert in laser refractive surgery, including LASIK, SMILE, PRK, as well as implantable technology including ICL and Refractive Lens Exchange.

Eric Garner Named OSRX Chief Commercial Officer

Rapid climb up executive ranks lands Garner at helm of all sales and marketing efforts for ophthalmic compounder. Since joining pharmaceutical startup OSRX® in March 2019 as director of marketing, Eric Garner has quickly ascended the corporate ladder.

Top 9 Reasons Surgeons Prescribe Compounded Post-Op Drops

Surgeons across America told us their reasons for prescribing compounded drops from OSRX®.

OSRX Launches Online Prescriber Portal

OSRX, the 503A compounding pharmacy affiliate of Southern California biotech Ocular Science®, today introduced an online portal designed to streamline and simplify the prescribing process. The OSRX Prescriber Portal, at osrxpharmaceuticals.com, is a simplified, secure process for submitting, tracking and managing patient scripts.

Why I Prescribe OMNI Combo Drops

Dr. Steven R. Sarkisian, Jr., is the founder and CEO of Oklahoma Eye Surgeons, PLLC, as well as the former director of the glaucoma fellowship at the Dean McGee Eye Institute and clinical professor of Ophthalmology at the University of Oklahoma.

As Profits Rise, Ocular Science Promotes From Within

Ocular Science, which produces and markets ophthalmic medications for post-op cataract and LASIK procedures, glaucoma management, myopia control and dry eye disease, has promoted Eric Garner to Vice President of Marketing.

ASCRS FDA Committee Member Speaks on Access to Compounded Drugs

ASCRS FDA committee member Damien Goldberg, MD, urges FDA to allow access to compounded drugs from traditional compounders without a patient-specific prescription.